University of Oxford

Oxford, Oxfordshire OX3 7LJ

1 studies enrolling now · 4 studies all time

What they study most

Acute Myocardial Infarction, Endometrial Cancer, Influenza, Low-grade Serous Ovarian Cancer, RSV, Recurrent Endometrial Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Cancer, Recurrent Primary Peritoneal Cancer, SARS-CoV-2, STEMI, Select Advanced Solid Tumors

Studies at this site

• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• A Study of Acute Myocardial Infarction Using FDY-5301 — Completed
• A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old — Completed